Eton Pharmaceuticals, Inc. ETON
51.03 USD +0.22 +0.43%
As of Nov 3, 12:18 PM ET
14.27 52-week range 66.37
- YTD
- +201.77%
- 1 year
- +184.13%
- Open
- 50.81
- Prev close
- 50.81
- Mkt cap
- 1.46B
- Vol
- 82.88K
- Avg vol
- 564.30K
- EPS
- 0.40
- P/E
- 127.55
- Div yield
- 0.00%
More statistics
- Low
- 50.77
- High
- 52.68
- Forward P/E
- 19.93
- Beta
- 0.83
- Short ratio
- 3.18
- Inst. own
- 71.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 56.00
- 200-d avg
- 35.71
- 1y target
- 71.50
MAX chart
Chart tools
Chart is warming up
The all-time price history for ETON has not been loaded yet. Try again in a moment.
Altman Z-Score
12.98 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 2
- P/E 1
- P/B 1
P/E -99.5×
P/S 5.7×
P/B 17.4×
P/FCF 44.6×
EV/EBITDA 108×
EV/Sales 5.8×
FCF Yield 2.2%
Gross Margin 53.5%
Operating Margin 0.1%
Net Margin -5.8%
ROE -17.6%
ROIC 0.1%
ROA -5.0%
Revenue 104.9%
Operating Income 102.8%
EPS (diluted) -13.3%
Free Cash Flow 980.7%
Current Ratio 1.6×
Quick Ratio 1.2×
Debt / Equity 1.2×
Net Debt / EBITDA 1.2×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31